Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
realSKIN for severe burn wounds
NCT06223269Phase 3Recruiting
- Sponsor
- XenoTherapeutics
- Start
- May 2024
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
A Phase 3 trial of realSKIN in Thermal Burn, sponsored by XenoTherapeutics. Started May 2024; status: recruiting.
02
Drugs
realSKIN
03
Conditions
Thermal Burn
Beyond the preview
Go deeper on NCT06223269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06223269.